Clinical Trial Update: HIV Prevention With PrEP Among People on Opioid Replacement Therapy [Phase 4]

View source ↗

Summary

Phase 4 clinical trial is recruiting to evaluate HIV prevention with pre-exposure prophylaxis (PrEP) among people on opioid replacement therapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Human Immunodeficiency Virus Infection

Snippet

Sponsor: Cara Spence | Conditions: HIV - Human Immunodeficiency Virus | Phase 4 | Status: RECRUITING